| |
Patients |
Sex |
Age |
EGIL Scores |
| B-Line |
T-Line |
Myeloid line |
| 1 |
A.R. |
M |
42 |
6.0 |
2.5 |
2.0 |
| 2 |
B.Z. |
F |
84 |
0 |
4.0 |
3.5 |
| 3 |
B.J. |
F |
76 |
0 |
4.5 |
4.5 |
| 4 |
B.L. |
F |
48 |
0 |
2.0 |
3.0 |
| 5 |
C.E. |
F |
47 |
0 |
3.0 |
4.5 |
| 6 |
D.S. |
M |
80 |
0 |
2.0 |
4.5 |
| 7 |
F.K. |
M |
29 |
6.0 |
2.5 |
4.5 |
| 8 |
J.R. |
M |
64 |
3.0 |
0 |
4.0 |
| 9 |
K.A. |
F |
45 |
0 |
2.0 |
2.0 |
| 10 |
K.E. |
F |
51 |
3.0 |
0 |
3.5 |
| 11 |
K.J. |
M |
49 |
4.0 |
0 |
1.5 |
| 12 |
L.K. |
F |
42 |
4.0 |
3.5 |
2.0 |
| 13 |
O.A. |
F |
68 |
3.0 |
6.0 |
2.5 |
| 14 |
P.K. |
F |
67 |
4.0 |
0 |
2.0 |
| 15 |
P.T. |
F |
25 |
0 |
2.0 |
2.5 |
| 16 |
P.T. |
M |
76 |
0 |
3.5 |
2.0 |
| 17 |
P.J. |
F |
26 |
0 |
3.0 |
3.0 |
| 18 |
R.I. |
F |
67 |
0 |
6.5 |
3.0 |
| 19 |
S.E. |
F |
60 |
0 |
4.5 |
3.5 |
| 20 |
S.M. |
F |
57 |
0 |
4.0 |
5.0 |
| 21 |
S.R. |
M |
63 |
0 |
3.5 |
2.5 |
| 22 |
S.K. |
M |
39 |
2.0 |
2.0 |
4.0 |
| 23 |
W.B. |
M |
61 |
0 |
2.0 |
2.5 |
| 24 |
W.E. |
F |
49 |
0 |
2.0 |
2.0 |
|
